fda glp-1 enforcement news october 2025 September 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines Attorney General Jeff Jackson Leads

For post-cholecystectomy patients, genetic insights are especially valuable

Not to mention the possible permanent lowering of digestive ability once off GLP-1s, along with the return of the body fat lost, if the situation that originally brought about the obesity has not been addressed

Prevention is better than aftercare

14.3 BYDUREON Glycemic Control Trials in Adults with Type 2 Diabetes Mellitus - Monotherapy BYDUREON, another exenatide extended-release product, has been studied as monotherapy in adult patients with type 2 diabetes mellitus

November 2025: One of the physicians and researchers who investigated the link between Wegovy and vision loss is continuing his research on a link between the drug and condition